High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Brenda Weigel, MD
Masonic Cancer Center, University of Minnesota
Study Chair - Carola A Arndt, MD
Mayo Clinic
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
166 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- John Hunter Hospital
Newcastle, New South Wales, Australia
- Westmead Institute for Cancer Research at Westmead Hospital
Westmead, New South Wales, Australia
- Royal Children'S Hospital
Herston, Brisbane, Queensland, Australia
- Women'S and Children'S Hospital
North Adelaide, South Australia, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Alberta Children'S Hospital
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Children'S & Women'S Hospital of British Columbia
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Janeway Children'S Health and Rehabilitation Centre
St. John's, Newfoundland and Labrador, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Cancer Centre of Southeastern Ontario at Kingston General Hospital
Kingston, Ontario, Canada
- Children'S Hospital of Western Ontario
London, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Saskatoon Cancer Centre at the University of Saskatchewan
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Swiss Pediatric Oncology Group Bern
Bern, Switzerland
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Phoenix Children'S Hospital
Phoenix, Arizona, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Jonathan Jaques Children'S Cancer Center at Miller Children'S Hospital
Long Beach, California, United States
- Childrens Hospital Los Angeles
Los Angeles, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital and Research Center Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Kaiser Permanente Medical Center - Oakland
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- University of California Davis Cancer Center
Sacramento, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Stanford Cancer Center
Stanford, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2006
- Primary completion
- 31 Jan 2010
- Completion
- 30 Jun 2019
- Last update posted
- 29 Jan 2020
- Registered enrollment
- 109
- Registry id
- NCT00354744
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.